What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care (DHSC)? What do these changes mean for your...
Read More
What does the abolition of NHS England mean for your market access and NHS Engagement strategy? How will the changes at national and integrated care board (ICB) level impact launch...
Read More
In June 2024, we joined Petauri, a purpose-built pharmaceutical services platform combining best-in-class companies with recognised expertise in global market access, medical affairs, patient services, and data and analytics. As part...
Read More
We are delighted to announce that Clare Foy (Director – Global Market Access), Hannah Palin (Director – Local Market Access), and Calum Jones (Associate Director – Health Economics) will be...
Read More
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Barcelona over the 18th–20th November 2024. Mtech Access experts will be joined by our colleagues from across Petauri, including...
Read More
What is IDAP? As the IDAP pilot opens, we explore how this new pathway offers a fast-track route to patient access for innovative medical technologies.
A symposium for UK market access leaders The healthcare landscape is continuously evolving, and the need for effective collaboration between the NHS and industry partners has never been more critical....
Read More
Louise Maddison joined Mtech Access as a Senior Consultant in our Market Access Team, earlier this year. Here, she talks about her career journey and her experiences since joining Mtech Access.
We're thrilled to announce that Mtech Access will be exhibiting at the ISPOR conference May 5–8 in Atlanta, Georgia, USA! As regular attendees of ISPOR Europe, we're excited to be...
Read More
